Logos Global Management LP Buys Olema Pharmaceuticals inc, Nkarta Inc, Kinnate Biopharma Inc, Sells Global Blood Therapeutics Inc, Keros Therapeutics Inc, Sarepta Therapeutics Inc

• New Purchases: OLMA, NKTX, KNTE, APLS, ALGS, IGMS, KRTX, ABCL, MRTX, CRIS, EPIX, STTK, LUNG, EYPT, PCVX, EAR, HLXA, UKJ2, TVTX, CERE, FSDC,
• Added Positions: COGT, LRMR, FMTX, KALV,
• Reduced Positions: KROS, TGTX, RPTX, CMPS, KYMR, CALT, HRMY, BTAI, OM, PMVP, PLRX, RNA, ATHA,
• Sold Out: GBT, SRPT, CLDX, CYTK, SAGE, AKUS, INBX, LSACU, RLAY, NARI, AFIB, ARYBU, RAPT,

For the details of Logos Global Management LP's stock buys and sells, go to https://www.gurufocus.com/guru/logos+global+management+lp/current-portfolio/portfolio

1. Olema Pharmaceuticals inc (OLMA) - 3,743,875 shares, 22.17% of the total portfolio. New Position
2. Nkarta Inc (NKTX) - 1,682,178 shares, 12.73% of the total portfolio. New Position
3. Forma Therapeutics Holdings Inc (FMTX) - 1,400,000 shares, 6.02% of the total portfolio. Shares added by 19.33%
4. TG Therapeutics Inc (TGTX) - 850,000 shares, 5.45% of the total portfolio. Shares reduced by 51.43%
5. Dyne Therapeutics Inc (DYN) - 1,604,392 shares, 4.15% of the total portfolio.

Logos Global Management LP initiated holding in Olema Pharmaceuticals inc. The purchase prices were between $37.09 and $54.5, with an estimated average price of $46.89. The stock is now traded at around $48.550000. The impact to a portfolio due to this purchase was 22.17%. The holding were 3,743,875 shares as of 2020-12-31.

Logos Global Management LP initiated holding in Nkarta Inc. The purchase prices were between $27.03 and $75.62, with an estimated average price of $41.72. The stock is now traded at around $55.630000. The impact to a portfolio due to this purchase was 12.73%. The holding were 1,682,178 shares as of 2020-12-31.

Logos Global Management LP initiated holding in Kinnate Biopharma Inc. The purchase prices were between $36.35 and $45.25, with an estimated average price of $40.13. The stock is now traded at around $35.160000. The impact to a portfolio due to this purchase was 2.79%. The holding were 569,602 shares as of 2020-12-31.

Logos Global Management LP initiated holding in Apellis Pharmaceuticals Inc. The purchase prices were between $30.79 and $57.2, with an estimated average price of $42.47. The stock is now traded at around $44.730000. The impact to a portfolio due to this purchase was 2.11%. The holding were 300,000 shares as of 2020-12-31.

Logos Global Management LP initiated holding in Aligos Therapeutics Inc. The purchase prices were between $13.2 and $32.74, with an estimated average price of $19.48. The stock is now traded at around $30.560000. The impact to a portfolio due to this purchase was 2.07%. The holding were 606,548 shares as of 2020-12-31.

Logos Global Management LP initiated holding in IGM Biosciences Inc. The purchase prices were between $47.41 and $115.03, with an estimated average price of $70.2. The stock is now traded at around $98.370000. The impact to a portfolio due to this purchase was 1.63%. The holding were 150,000 shares as of 2020-12-31.

Logos Global Management LP added to a holding in Cogent Biosciences Inc by 184.52%. The purchase prices were between $9.36 and $13.01, with an estimated average price of $11.02. The stock is now traded at around $9.620000. The impact to a portfolio due to this purchase was 1.73%. The holding were 1,920,500 shares as of 2020-12-31.

Logos Global Management LP added to a holding in Larimar Therapeutics Inc by 116.67%. The purchase prices were between $14.28 and $25.06, with an estimated average price of $20.11. The stock is now traded at around $18.790000. The impact to a portfolio due to this purchase was 1.02%. The holding were 715,000 shares as of 2020-12-31.

Logos Global Management LP added to a holding in KalVista Pharmaceuticals Inc by 63.33%. The purchase prices were between $12.97 and $19.47, with an estimated average price of $17.22. The stock is now traded at around $42.100000. The impact to a portfolio due to this purchase was 0.45%. The holding were 490,000 shares as of 2020-12-31.

Logos Global Management LP sold out a holding in Global Blood Therapeutics Inc. The sale prices were between $37.65 and $63.77, with an estimated average price of $49.17.

Logos Global Management LP sold out a holding in Sarepta Therapeutics Inc. The sale prices were between $125.56 and $178.74, with an estimated average price of $148.28.

Logos Global Management LP sold out a holding in Celldex Therapeutics Inc. The sale prices were between $14.99 and $22.75, with an estimated average price of $18.05.

Logos Global Management LP sold out a holding in Cytokinetics Inc. The sale prices were between $15.26 and $28.61, with an estimated average price of $18.21.

Logos Global Management LP sold out a holding in Sage Therapeutics Inc. The sale prices were between $58.41 and $89.06, with an estimated average price of $73.93.

Logos Global Management LP sold out a holding in Akouos Inc. The sale prices were between $17.03 and $22.44, with an estimated average price of $19.44.